BCL2L1 and head and neck squamous cell carcinoma: A recent finding demonstrated that co-inhibition of MCL-1 and BCL-XL was feasible in a zebrafish model of head and neck squamous cell carcinoma [20] and embryonic chicken model of rhabdomyosarcoma (RMS) [22].